Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.865
+0.095 (5.37%)
At close: Sep 17, 2026, 4:00 PM EDT
1.865
0.00 (0.00%)
After-hours: Sep 17, 2026, 4:10 PM EDT
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,146,697
Market Cap
49.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| eXoZymes | 32 |
| Tevogen | 18 |
| ImageneBio | 18 |
| Instil Bio | 17 |
| Edesa Biotech | 17 |
| Apollomics | 14 |
| Hyperion DeFi | 9 |
| Annovis Bio | 7 |
ELTX News
- 3 days ago - Elicio Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 9 days ago - Elicio Therapeutics Slides: Corporate presentation - Filings
- 17 days ago - Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 23 days ago - Elicio Therapeutics Slides: Corporate presentation - Filings
- 24 days ago - Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Elicio Therapeutics reports Q2 EPS (43c), consensus (54c) - TheFly
- 5 weeks ago - Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 weeks ago - Elicio Therapeutics Quarterly report: Q2 2026 - Filings